Biotransformation of deprenyl enantiomers

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 4, 1999, Pages 315-319

  Szoko E ^a,b   Kalasz H ^a   Magyar, K ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Capillary electrophoresis; Deprenyl enantiomer; Stereoselective metabolism

Indexed keywords

AMPHETAMINE; METHAMPHETAMINE; SELEGILINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DEALKYLATION; DRUG METABOLISM; DRUG TRANSFORMATION; ENANTIOMER; HEART; KIDNEY; LIVER; MALE; NONHUMAN; PLASMA; RAT; TISSUE HOMOGENATE;

EID: 0343183092     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190039     Document Type: Article

References (13)

1. Knoll J., Magyar K. (1972) : Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv. Biochem. Psychopharmacol., 5, 393-408.
2. Magyar K., Szende B., Lengyel J., Tekes K. (1996) : The pharmacology of B-type selective monoamine oxidase inhibitors: milestones in (-)-deprenyl research. J. Neural Transm., 48, 29-43.
3. Magyar K., Vizi E.S., Ecseri Z., Knoll J. (1967) : Comparative pharmacological analysis of the optical isomers of phenyl-isopropyl-methyl-propinylamine (E250). Acta Physiol. Hung., 32, 377-387
4. Szökõ É., Magyar K. (1996) : Enantiomer identification of the major metabolites of (-)-deprenyl in rat urine by capillary electrophoresis. Int. J. Pharm. Adv., 1, 320-326.
5. Szökõ É., Magyar K. (1995) : Chiral separation of deprenyl and its major metabolites using cyclodextrin-modified capillary zone electrophoresis. J. Chromatogr. A, 709, 157-162.
6. Yoshida T., Yamada Y., Yamamoto T., Kuroiwa Y. (1986) : Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO B inhibitory potency. Xenobiotica, 2, 129-136.
7. Szebeni G., Lengyel J., Székács G., Magyar K., Gaál J., Szatmári I. (1995) : Gas Chromatographic procedure for simultaneous determination of selegiline metabolites, amphetamine, methamphetamine, and demethyl-deprenyl in pig plasma. Acta Physiol. Hung., 83, 135-141.
8. Heinonen E.H., Anttila M.I., Lammintausta R.A.S. (1994) : Pharmacokinetic aspects of 1-deprenyl (selegiline) and its metabolites. Clin. Pharmacol. Ther., 56, 742-749.
9. Lengyel J., Magyar K., Hollósi I. et al. (1996) : Urinary excretion of deprenyl metabolites. J. Chromatogr. A, 762, 321-326.
10. Kalász H., Kerecsen L., Knoll J., Pucsok J. (1990) : Chromatographic studies on the binding, action and metabolism of (-)-deprenyl. J. Chromatogr., 499, 589-599.
11. Yoshida T., Oguro T., Kuroiwa Y. (1987) : Hepatic and extrahepatic metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor, of amphetamines in rats: sex and strain differences. Xenobiotica, 17, 957-963.
12. Meeker J.E., Reynolds P.C. (1990) : Postmortem tissue methamphetamine concentrations following selegiline administration. J. Anal. Toxicol., 14. 330-331.
13. 3H in rat brain. Prog. Brain Res., 106, 143-153.